Novartis AG Additions Other Than Through Business Combinations Intangible Assets Other Than Goodwill
Novartis AG (NVS) reported Additions Other Than Through Business Combinations Intangible Assets Other Than Goodwill of $1.86 billion for the 3-month period ending 2025-06-30, per its 6-K filed 2025-07-17.
Financial Statements › Notes › Intangible Assets
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill · last filed 2025-07-17
- Novartis AG additions other than through business combinations intangible assets other than goodwill for the quarter ending 2025-06-30 was $1.86B, a 263.67% increase year-over-year.
- Novartis AG additions other than through business combinations intangible assets other than goodwill for the quarter ending 2024-06-30 was $512.00M, a 1.73% decline year-over-year.
- Novartis AG additions other than through business combinations intangible assets other than goodwill for the quarter ending 2023-06-30 was $521.00M.
| Period end | Additions Other Than Through Business Combinations Intangible Assets Other Than Goodwill 3 month | Additions Other Than Through Business Combinations Intangible Assets Other Than Goodwill 6 month | Additions Other Than Through Business Combinations Intangible Assets Other Than Goodwill 12 month |
|---|---|---|---|
| 2025-06-30 | $1.86B 6-K · filed 2025-07-17 | $3.04B 6-K · filed 2025-07-17 | |
| 2024-06-30 | $512.00M 6-K · filed 2025-07-17 | $1.18B 6-K · filed 2025-07-17 | |
| 2023-06-30 | $521.00M 6-K · filed 2024-07-18 | $716.00M 6-K · filed 2024-07-18 | |
| 2022-12-31 | $2.09B 20-F/A · filed 2023-05-15 | ||
| 2021-12-31 | $1.74B 20-F/A · filed 2023-05-15 | ||
| 2020-12-31 | $1.43B 20-F · filed 2022-02-02 | ||
| 2019-12-31 | $767.00M 20-F · filed 2021-01-26 | ||
| 2018-12-31 | $1.59B 20-F · filed 2020-01-29 | ||
| 2017-12-31 | $1.15B 20-F · filed 2019-01-30 | ||
| 2016-12-31 | $978.00M 6-K · filed 2018-01-24 |